DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients

Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation

(2015) Martin Lauss et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma

(2015) Christina Dahl et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis

(2015) Érica S.S. De Araújo et al.   MELANOMA RESEARCH

Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population

(2015) Hong Zhang et al.   Clinics and Research in Hepatology and Gastroenterology

On the presence and role of human gene-body DNA methylation

(2015) Daudi Jjingo et al.   Oncotarget

Risk Prediction Models for Melanoma: A Systematic Review

(2014) J. A. Usher-Smith et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

MITF in melanoma: mechanisms behind its expression and activity

(2014) Mariusz L. Hartman et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Constitutional promoter methylation and risk of familial melanoma

(2014) Paula L Hyland et al.   Epigenetics

Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma

(2014) Alexandre Leon Ribeiro de Ávila et al.   Familial Cancer

Deletion of theMGMTgene in familial melanoma

(2014) Frida Appelqvist et al.   GENES CHROMOSOMES & CANCER

MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma

(2014) Rainer Tuominen et al.   INTERNATIONAL JOURNAL OF CANCER

Blood DNA methylation, nevi number, and the risk of melanoma

(2014) Laura Pergoli et al.   MELANOMA RESEARCH

POT1 loss-of-function variants predispose to familial melanoma

(2014) Carla Daniela Robles-Espinoza et al.   NATURE GENETICS

Single-cell gene expression signatures reveal melanoma cell heterogeneity

(2014) M Ennen et al.   ONCOGENE

The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis

(2014) Simon J. Furney et al.   Pigment Cell & Melanoma Research

DNA Methylation Characteristics of Primary Melanomas with Distinct Biological Behaviour

(2014) Szilvia Ecsedi et al.   PLoS One

Assessment of PALB2 as a Candidate Melanoma Susceptibility Gene

(2014) Lauren G. Aoude et al.   PLoS One

Melanoma in Non-Caucasian Populations

(2014) Jonathan Stubblefield et al.   SURGICAL CLINICS OF NORTH AMERICA

Role of MGMT as biomarker in colorectal cancer

(2014) Alessandro Inno   World Journal of Clinical Cases

Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer

(2013) Marta Kulis et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

ChAMP: 450k Chip Analysis Methylation Pipeline

(2013) Tiffany J. Morris et al.   BIOINFORMATICS

The Role of MGMT Testing in Clinical Practice

(2013) Milena Cankovic et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

TERT Promoter Mutations in Familial and Sporadic Melanoma

(2013) S. Horn et al.   SCIENCE

IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data

(2012) D. Wang et al.   BIOINFORMATICS

The Value of a Tumor Bank in the Development of Cancer Research in Brazil: 13 Years of Experience at the A C Camargo Hospital

(2012) Antonio Hugo Jose Froes Marques Campos et al.   BIOPRESERVATION AND BIOBANKING

DNA methylation biomarkers in cancer: progress towards clinical implementation

(2012) Thomas Mikeska et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Melanoma: from mutations to medicine

(2012) H. Tsao et al.   GENES & DEVELOPMENT

Melanoma Genetics: Recent Findings Take Us Beyond Well-Traveled Pathways

(2012) Matthew H. Law et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

DNA methylation profiling in the clinic: applications and challenges

(2012) Holger Heyn et al.   NATURE REVIEWS GENETICS

Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07

(2012) PETER SCHRAML et al.   ONCOLOGY REPORTS

Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell death

(2012) Carla A. Brohem et al.   Pigment Cell & Melanoma Research

Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families

(2012) Ching-Ni Jenny Njauw et al.   PLoS One

Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients

(2011) Luca Sigalotti et al.   Journal of Translational Medicine

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

(2011) Satoru Yokoyama et al.   NATURE

Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls

(2011) Katrina S. Pedersen et al.   PLoS One

Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer

(2010) E. M. Wong et al.   Cancer Prevention Research

Germline Epigenetic Silencing of the Tumor Suppressor Gene PTPRJ in Early-Onset Familial Colorectal Cancer

(2010) Ramprasath Venkatachalam et al.   GASTROENTEROLOGY

TSLC1 gene silencing in cutaneous melanoma

(2010) Yan You et al.   MELANOMA RESEARCH

CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma

(2009) A. Tanemura et al.   CLINICAL CANCER RESEARCH

Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer

(2009) H. Pinheiro et al.   HUMAN MOLECULAR GENETICS

Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients

(2009) James M. Flanagan et al.   HUMAN MOLECULAR GENETICS

Fifteen-year quest for microphthalmia-associated transcription factor target genes

(2009) Yann Cheli et al.   Pigment Cell & Melanoma Research

An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer

(2009) Andrew E. Teschendorff et al.   PLoS One

Promoter Hypermethylation of the PALB2 Susceptibility Gene in Inherited and Sporadic Breast and Ovarian Cancer

(2008) A. Potapova et al.   CANCER RESEARCH

KIT Gene Mutations and Copy Number in Melanoma Subtypes

(2008) C. Beadling et al.   CLINICAL CANCER RESEARCH

Absence of Germline Epimutation of the CDKN2A Gene in Familial Melanoma

(2008) Remco van Doorn et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study

(2008) Lee E Moore et al.   LANCET ONCOLOGY

Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability

(2008) Heike C. Pieper et al.   NEUROBIOLOGY OF DISEASE

Genetic and epigenetic inactivation ofTNFRSF10Cin human prostate cancer

(2008) Yu Cheng et al.   PROSTATE